
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic Down-Selection of Repurposed Drug Candidates for COVID-19
Christopher A. MacRaild, Muzaffar-Ur-Rehman Mohammed, Faheem Faheem, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11851-11851
Open Access | Times Cited: 10
Christopher A. MacRaild, Muzaffar-Ur-Rehman Mohammed, Faheem Faheem, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11851-11851
Open Access | Times Cited: 10
Showing 10 citing articles:
In silico Evaluation of Bisphosphonates Identifies Leading candidates for SARS-CoV-2 RdRp inhibition
Muzaffar-Ur-Rehman Mohammed, Kishor Suryakant Chougule, Ala Chandu, et al.
Journal of Molecular Graphics and Modelling (2025) Vol. 136, pp. 108939-108939
Closed Access
Muzaffar-Ur-Rehman Mohammed, Kishor Suryakant Chougule, Ala Chandu, et al.
Journal of Molecular Graphics and Modelling (2025) Vol. 136, pp. 108939-108939
Closed Access
Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection
Alexander J. McAuley, Petrus Jansen van Vuren, Muzaffar-Ur-Rehman Mohammed, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2417-2417
Open Access | Times Cited: 13
Alexander J. McAuley, Petrus Jansen van Vuren, Muzaffar-Ur-Rehman Mohammed, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2417-2417
Open Access | Times Cited: 13
On Bisphosphonates and COVID-19: In Silico Model Suggests Inhibition of SARS-CoV-2 RdRp as Potential Explanation
Muzaffar-Ur-Rehman Mohammed, Kishore Suryakant Chougule, Ala Chandu, et al.
(2024)
Open Access | Times Cited: 2
Muzaffar-Ur-Rehman Mohammed, Kishore Suryakant Chougule, Ala Chandu, et al.
(2024)
Open Access | Times Cited: 2
Molecular Docking and Dynamics Identify Potential Drugs to be Repurposed as SARS-CoV-2 Inhibitors
Mohammed Muzaffar-Ur-Rehman, Chougule Kishore Suryakant, Ala Chandu, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 23, Iss. 02, pp. 137-159
Open Access | Times Cited: 3
Mohammed Muzaffar-Ur-Rehman, Chougule Kishore Suryakant, Ala Chandu, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 23, Iss. 02, pp. 137-159
Open Access | Times Cited: 3
Molecular Docking and Dynamics Identifies Potential Repurposed Drug Candidates for COVID-19 Studies
Mohammed Muzaffar-Ur-Rehman, Chougule Kishor Suryakant, Ala Chandu, et al.
(2023)
Open Access | Times Cited: 2
Mohammed Muzaffar-Ur-Rehman, Chougule Kishor Suryakant, Ala Chandu, et al.
(2023)
Open Access | Times Cited: 2
Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection
Nathan Gödde, Carmel O’Brien, Elizabeth Vincan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nathan Gödde, Carmel O’Brien, Elizabeth Vincan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Quantum Chemical Study on the Anti-SARS-CoV-2 Activity of TMPRSS2 Inhibitors
Akihiro Kondo, Kazuhiro J. Fujimoto, Takeshi Yanai
(2023)
Open Access | Times Cited: 1
Akihiro Kondo, Kazuhiro J. Fujimoto, Takeshi Yanai
(2023)
Open Access | Times Cited: 1
A quantum chemical study on the anti-SARS-CoV-2 activity of TMPRSS2 inhibitors
Akihiro Kondo, Kazuhiro J. Fujimoto, Takeshi Yanai
Physical Chemistry Chemical Physics (2023) Vol. 25, Iss. 30, pp. 20597-20605
Open Access | Times Cited: 1
Akihiro Kondo, Kazuhiro J. Fujimoto, Takeshi Yanai
Physical Chemistry Chemical Physics (2023) Vol. 25, Iss. 30, pp. 20597-20605
Open Access | Times Cited: 1
Use of Human Lung Tissue Models for Screening of Drugs Against SARS-CoV-2 Infection
Alexander J. McAuley, Petrus Jansen van Vuren, Muzaffar-Ur-Rehman Mohammed, et al.
(2022)
Open Access | Times Cited: 2
Alexander J. McAuley, Petrus Jansen van Vuren, Muzaffar-Ur-Rehman Mohammed, et al.
(2022)
Open Access | Times Cited: 2
Leaning on repurposed drug candidates to fight COVID-19
K. S. Jayaraman
Nature India (2022)
Closed Access
K. S. Jayaraman
Nature India (2022)
Closed Access